Exelixis Inc
$58.49
$1.71 (+3.01%)
$57.23Day Range$58.52
Key Statistics
Market Cap
$14.07B
Shares Outstanding
247.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Apr 11, 2000
Round Lot
100
Locale
US
Trading Data
Day Open
$57.23
Day High
$58.52
Day Low
$57.23
Volume
1.79M
VWAP
$58.18
Prev Close
$56.78
Transactions
--
Acc. Volume
--
About Exelixis Inc
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)SIC 28361,077 employees1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502(650) 837-7000IPO Apr 11, 2000US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000939767
- Composite FIGI
- BBG000BQ4WF8
- Share Class FIGI
- BBG001SD42W4
- Ticker Root
- EXEL
- SIC Code
- 2836
About Exelixis Inc (EXEL) Stock
Exelixis Inc (EXEL) closed the 2026-09-17 session at $58.49, up 3.01% versus the previous close (+1.71). The stock opened at $57.23 and traded between $57.23 and $58.52 during that session. Session trading volume was 1.8M shares. The volume-weighted average price (VWAP) is $58.18.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
Exelixis Inc has a market capitalization of $14.07 billion. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. EXEL is listed on the XNAS exchange. The company employs approximately 1,077 people. Exelixis Inc is headquartered in ALAMEDA, CA. The recorded listing date is 2000-04-11.
On this page you can find market EXEL stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.